Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpAMEX:STVN N 87 Interest Coverage is 39.91 as of Jun. 2026, which is 30% above its 10-year median of 30.67. GuruFocus rates MEX:STVN N with a GF Score™ of 87/100 and a GF Value™ of MXN315.25. The stock has 6 warning signs investors should review. Among 461 Medical Devices & Instruments companies, Stevanato Group SpA ranks better than 57.92% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Stevanato Group SpA's
Operating Income
for the
three
months ended in Jun. 2026 was MXN1,031 Mil. Stevanato Group SpA's Interest Expense for the
three
months ended in Jun. 2026 was MXN-26 Mil.
Stevanato Group SpA's interest coverage for the quarter that ended in Jun. 2026 was 39.91.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Stevanato Group SpA's Interest Coverage or its related term are showing as below:
MEX:STVN N'
s Interest Coverage Range Over the Past 10 Years
Min: 11.1 Med: 30.67 Max: 48.9
Current: 28.23
MEX:STVN N's Interest Coverage is ranked better than 57.92% of 461
companies
in the Medical Devices & Instruments industry
Industry Median: 16.6
vs MEX:STVN N: 28.23
Stevanato Group SpA (MEX:STVN N) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Stevanato Group SpA Interest Coverage Related Terms
Stevanato Group SpA Interest Coverage Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEX:STVN N vs MMED, TFX, MMSI: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA (MEX:STVN N) has a Interest Coverage of 39.91 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Stevanato Group SpA and its competitors. This is 30% above median its historical median of 30.67. Over the past decade, Stevanato Group SpA's Interest Coverage has ranged from 11.10 to 48.90. According to the industry distribution chart, Stevanato Group SpA ranks #194 out of 461 companies in the Medical Devices & Instruments industry, placing it in the top 42.1%.
Is Stevanato Group SpA's Interest Coverage too high?
Stevanato Group SpA's current Interest Coverage of 39.91 is 30% above median its 10-year median of 30.67. Over the past 10 years, this metric has ranged from a low of 11.10 to a high of 48.90. The Medical Devices & Instruments industry median Interest Coverage is 16.60. Stevanato Group SpA's value of 39.91 is 140.4% above this industry median. Based on the distribution chart, Stevanato Group SpA ranks #194 out of 461 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Interest Coverage compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #194 out of 461 companies for Interest Coverage. This puts Stevanato Group SpA in the upper half of its industry. The industry median Interest Coverage is 16.60. Stevanato Group SpA's value of 39.91 is 140.4% above this benchmark. Historically, Stevanato Group SpA's own Interest Coverage has ranged from 11.10 to 48.90 over the past decade. While the company's 10-year median is 30.67 vs. the industry median of 16.60, Stevanato Group SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.60, based on 461 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Interest Coverage of 39.91 is 140.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Interest Coverage is 39.91, which is 30% above median its own 10-year median of 30.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Stevanato Group SpA (MEX:STVN N) has a current Interest Coverage of 39.91. The stock's GF Value™ is MXN315.25, compared to a current price of MXN246.00 — trading 22% below its estimated fair value. The current Interest Coverage is 39.91, which is 30% above median its 10-year median of 30.67 and 140.4% above the Medical Devices & Instruments industry median of 16.60. Stevanato Group SpA's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Stevanato Group SpA (MEX:STVN N), the current Interest Coverage is 39.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (MEX:STVN N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of MXN246.00 is trading 22% below its estimated GF Value™ of MXN315.25.
Key valuation signals for MEX:STVN N:
Interest Coverage: 39.91 (30% above median its 10-year median of 30.67)
GF Value™: MXN315.25 vs. price of MXN246.00 (22% below fair value)
Industry Position: 140.4% above the Medical Devices & Instruments median (#194 of 461)
No single metric tells the full story. See the MEX:STVN N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
87GF Score
Get the complete analysis for MEX:STVN N
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STVN N has been successfully added to your 
